Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 4/2017

Ausgabe 4/2017

Inhaltsverzeichnis ( 23 Artikel )

18.07.2017 | Review Article | Ausgabe 4/2017

Antiangiogenic tyrosine kinase inhibitors in colorectal cancer: is there a path to making them more effective?

Thomas B. Karasic, Mark A. Rosen, Peter J. O’Dwyer

04.08.2017 | Original Article | Ausgabe 4/2017 Open Access

Hyponatremia and V2 vasopressin receptor upregulation: a result of HSP90 inhibition

Qiong Yang, Florian Puhm, Michael Freissmuth, Christian Nanoff

04.08.2017 | Original Article | Ausgabe 4/2017

Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer

Shengshi Huang, Di Wang, Shu Zhang, Xiaoyan Huang, Dandan Wang, Muhammad Ijaz, Yikang Shi

07.08.2017 | Original Article | Ausgabe 4/2017

The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group

Munetaka Takekuma, Keita Mori, Tetsuji Iida, Kazuko Kurihara, Motoaki Saitou, Hideki Tokunaga, Kei Kawana, Masae Ikeda, Toyomi Satoh, Toshiaki Saito, Etsuko Miyagi, Yutaka Nagai, Akiko Furusawa, Yoshiaki Kawano, Kouichiro Kawano, Tsutomu Tabata, Yukinobu Ota, Ryoji Hayase, Mikio Mikami, Toru Sugiyama

28.08.2017 | Original Article | Ausgabe 4/2017

A phase II study of modified docetaxel, cisplatin, and S-1 (mDCS) chemotherapy for unresectable advanced gastric cancer

Naoki Uemura, Shohei Kikuchi, Yasushi Sato, Hiroyuki Ohnuma, Koichi Okamoto, Hiroshi Miyamoto, Masahiro Hirakawa, Tamotsu Sagawa, Koshi Fujikawa, Yasuo Takahashi, Toshinori Okuda, Shinya Minami, Minoru Takahashi, Tetsuro Okamoto, Kohichi Takada, Koji Miyanisi, Tetsuji Takayama, Junji Kato

14.08.2017 | Original Article | Ausgabe 4/2017

Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma

Michael A. Badruddoja, Marjorie Pazzi, Abhay Sanan, Kurt Schroeder, Kevin Kuzma, Thomas Norton, Thomas Scully, Daruka Mahadevan, Michael Malek Ahmadi

03.08.2017 | Original Article | Ausgabe 4/2017

Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect

Tamás Solymosi, Zsolt Ötvös, Réka Angi, Betti Ordasi, Tamás Jordán, László Molnár, John McDermott, Vanessa Zann, Ann Church, Stuart Mair, Genovéva Filipcsei, Gábor Heltovics, Hristos Glavinas

05.08.2017 | Original Article | Ausgabe 4/2017

Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and review

Jung Han Kim, Bum Jun Kim, Hyun Joo Jang, Hyeong Su Kim

11.08.2017 | Original Article | Ausgabe 4/2017

Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin

N. Blank, I. Laskov, R. Kessous, L. Kogan, S. Lau, I. A. Sebag, Walter H. Gotlieb, L. Rudski

07.08.2017 | Original Article | Ausgabe 4/2017

Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis

Mohamed M. Abdel-Daim, Omnia E. kilany, Hesham A. Khalifa, Amal A. M. Ahmed

01.09.2017 | Original Article | Ausgabe 4/2017 Open Access

A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men

Richard Markus, Vincent Chow, Zhiying Pan, Vladimir Hanes

08.09.2017 | Original Article | Ausgabe 4/2017

MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells

Azam Rajabpour, Ali Afgar, Habibollah Mahmoodzadeh, Jalal-e-Din Radfar, Farzad Rajaei, Ladan Teimoori-Toolabi

19.08.2017 | Original Article | Ausgabe 4/2017

Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer

Katsuki Danno, Taishi Hata, Koki Tamai, Yujiro Fujie, Yoshihito Ide, Ho Min Kim, Tadashi Ohnishi, Shunji Morita, Shinichi Yoshioka, Toshihiro Kudo, Junichi Nishimura, Chu Matsuda, Hiroki Akamatsu, Tsunekazu Mizushima, Riichiro Nezu, Yuichiro Doki, Masaki Mori, Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO)

30.08.2017 | Original Article | Ausgabe 4/2017

Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value

Keith M. Skubitz, Anne H. Blaes, Suma H. Konety, Gary S. Francis

07.09.2017 | Original Article | Ausgabe 4/2017

Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea

Kyong Joo Lee, Jae Hee Cho, Sang Hyub Lee, Si Young Song, Kwang Hyuk Lee, Seok Jeong, Ji Kon Ryu, Sang Myung Woo, Seungmin Bang, Jong Kyun Lee, Tae Hoon Lee, Woo Hyun Paik, Yong Tae Kim, Woo Jin Lee

18.08.2017 | Original Article | Ausgabe 4/2017

Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy

Shigenori Kadowaki, Toshiki Masuishi, Tetsuya Eto, Yukiya Narita, Hiroya Taniguchi, Takashi Ura, Masashi Ando, Masahiro Tajika, Yasumasa Niwa, Yasushi Yatabe, Kei Muro

31.08.2017 | Original Article | Ausgabe 4/2017 Open Access

Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma

E. Fiedor, E. L. Gregoraszczuk

23.08.2017 | Original Article | Ausgabe 4/2017

Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia

Islem Ben Hassine, Hanene Gharbi, Ismail Soltani, Hind Ben Hadj Othman, Ahlem Farrah, Hassiba Amouri, Mouheb Teber, Hela Ghedira, Yosra Ben Youssef, Ines Safra, Salem Abbes, Samia Menif

01.09.2017 | Original Article | Ausgabe 4/2017

Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer

Nao Tagawa, Erika Sugiyama, Masataka Tajima, Yasutsuna Sasaki, Seigo Nakamura, Hiromi Okuyama, Hisanori Shimizu, Vilasinee Hirunpanich Sato, Tadanori Sasaki, Hitoshi Sato

28.07.2017 | Clinical Trial Report | Ausgabe 4/2017

Significance of glucocorticoid receptor expression in patients with non-small cell lung cancer treated with pemetrexed-based chemotherapy

Xin-min Zhao, Jing Zhao, Xiang-hua Wu, Zhi-guo Luo, Hui-jie Wang, Hui Yu, Jian-hua Chang, Jia-lei Wang

29.07.2017 | Short Communication | Ausgabe 4/2017 Open Access

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition

Gayathri Srinivasan, Gurjit Singh Sidhu, Elizabeth A. Williamson, Aruna S. Jaiswal, Nasreen Najmunnisa, Keith Wilcoxen, Dennie Jones, Thomas J. George Jr., Robert Hromas

04.08.2017 | Short Communication | Ausgabe 4/2017

Continuous low plasma concentrations of everolimus provides equivalent efficacy to oral daily dosing in mouse xenograft models of human cancer

Laurent Laborde, Fatos Oz, Mitko Ristov, Daniel Guthy, Dario Sterker, Paul McSheehy

07.09.2017 | Letter to the Editor | Ausgabe 4/2017

Optimism and the continued promise of maintenance chemotherapy

John P. Micha, Bram Goldstein, Maurie Markman

Aktuelle Ausgaben


 

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise